EE5 COST-EFFECTIVENESS OF ATORVASTATIN IN TYPE 2 DIABETES PATIENTS- A PHARMACO-ECONOMIC ANALYSIS OF THE COLLABORATIVE ATORVASTATIN DIABETES STUDY (CARDS) IN THE BELGIAN POPULATION
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66189-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)66189-X/fulltext
Title :
EE5 COST-EFFECTIVENESS OF ATORVASTATIN IN TYPE 2 DIABETES PATIENTS- A PHARMACO-ECONOMIC ANALYSIS OF THE COLLABORATIVE ATORVASTATIN DIABETES STUDY (CARDS) IN THE BELGIAN POPULATION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66189-X&doi=10.1016/S1098-3015(10)66189-X
First page :
Section Title :
Open access? :
No
Section Order :
23